KWALITY PHARMACEUTICALS
Back to Balance Sheet
|
KWALITY PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-1.62 Cr | ₹-0.03 Cr | ₹0.41 Cr | ₹0.28 Cr | ₹-0.04 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of KWALITY PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-1.62 Cr |
| Mar2024 | ₹-0.03 Cr |
| Mar2023 | ₹0.41 Cr |
| Mar2022 | ₹0.28 Cr |
| Mar2021 | ₹-0.04 Cr |
How is Deferred Tax Assets / Liabilities of KWALITY PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.62 Cr | Negative | |
| Mar2024 | ₹-0.03 Cr | Negative | |
| Mar2023 | ₹0.41 Cr | 49.45 | |
| Mar2022 | ₹0.28 Cr | Positive | |
| Mar2021 | ₹-0.04 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹1,726.7 Cr | 14.4% | 46% | 135.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | 14.4% |
46% |
135.9% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses